Advanced Enzyme Technologies Ltd

Advanced Enzyme Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Advanced Enzyme Technologies Ltd

₹ 341 3.17%
13 Nov - close price
advancedenzymes.com BSE: 540025 NSE: ADVENZYMES
About

Advanced Enzyme Technologies Limited is engaged in the business of manufacturing and sales of enzymes.[1]

Key Points

Market Position
The Co. is the 1st Indian enzyme company with 2nd highest market share in India. It is the 2nd listed integrated enzyme player globally. [1]

Website BSE NSE
  • Market Cap ₹ 3,818 Cr.
  • Current Price ₹ 341
  • High / Low ₹ 412 / 258
  • Stock P/E 31.2
  • Book Value ₹ 60.0
  • Dividend Yield 1.52 %
  • ROCE 19.9 %
  • ROE 16.9 %
  • Face Value ₹ 2.00
Edit ratios

Pros

  • Company is almost debt free.
  • Company is expected to give good quarter
  • Company has been maintaining a healthy dividend payout of 43.2%

Cons

  • The company has delivered a poor sales growth of 7.28% over past five years.
  • Earnings include an other income of Rs.62.9 Cr.
  • Promoter holding has decreased over last 3 years: -6.80%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Biotechnology

Part of BSE Healthcare BSE SmallCap BSE Allcap Nifty Microcap 250 Nifty Total Market

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025
77 80 83 85 97 91 92 86 77 101 87 125 116
58 58 59 61 70 67 63 65 64 79 73 94 86
Operating Profit 19 21 23 25 27 25 29 21 14 22 14 31 30
OPM % 25% 27% 28% 29% 28% 27% 32% 24% 17% 22% 16% 24% 26%
2 4 3 51 1 4 -16 54 2 1 5 54 3
Interest 0 0 0 0 0 0 0 0 0 0 0 0 0
Depreciation 3 3 3 3 3 3 3 3 3 3 3 3 3
Profit before tax 18 22 23 73 25 25 10 72 12 21 16 81 30
Tax % 26% 25% 25% 8% 26% 25% 70% 7% 26% 26% 29% 9% 25%
14 17 18 67 18 19 3 67 9 15 11 74 22
EPS in Rs 1.22 1.49 1.56 6.04 1.64 1.71 0.28 6.00 0.82 1.36 0.99 6.61 1.99
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
135 125 139 173 212 222 247 283 273 312 365 351 429
107 91 103 124 162 169 170 183 200 236 260 280 332
Operating Profit 28 34 36 48 50 53 77 101 73 76 105 71 96
OPM % 21% 27% 26% 28% 24% 24% 31% 36% 27% 24% 29% 20% 22%
1 1 1 6 5 6 9 7 9 9 40 61 63
Interest 8 5 4 3 3 3 1 0 0 0 0 1 0
Depreciation 9 8 7 8 8 9 9 9 10 10 11 11 12
Profit before tax 12 23 25 44 44 47 76 98 72 74 134 121 147
Tax % 16% 14% 18% 21% 18% 25% 24% 28% 24% 25% 19% 15%
10 20 21 35 36 35 58 71 55 56 108 102 122
EPS in Rs 0.91 1.81 1.92 3.10 3.22 3.16 5.19 6.36 4.88 4.97 9.67 9.15 10.95
Dividend Payout % 11% 6% 10% 13% 16% 19% 12% 14% 21% 20% 53% 57%
Compounded Sales Growth
10 Years: 11%
5 Years: 7%
3 Years: 9%
TTM: 24%
Compounded Profit Growth
10 Years: 18%
5 Years: 12%
3 Years: 24%
TTM: 12%
Stock Price CAGR
10 Years: %
5 Years: 1%
3 Years: 7%
1 Year: -10%
Return on Equity
10 Years: 15%
5 Years: 16%
3 Years: 17%
Last Year: 17%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Sep 2025
Equity Capital 22 22 22 22 22 22 22 22 22 22 22 22 22
Reserves 116 134 152 233 267 297 348 413 458 503 558 607 649
59 38 49 38 45 18 10 1 2 2 2 3 2
31 28 37 25 39 38 42 53 48 48 51 57 76
Total Liabilities 228 223 261 318 373 376 423 490 530 576 633 689 749
110 106 101 98 98 97 127 132 132 143 142 156 152
CWIP 2 5 7 8 10 7 10 7 9 11 22 21 31
Investments 28 27 53 103 120 120 121 184 189 201 256 290 309
88 84 99 108 145 151 165 166 200 220 213 221 257
Total Assets 228 223 261 318 373 376 423 490 530 576 633 689 749

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
18 33 22 21 23 35 46 84 37 50 52 63
-7 -7 -27 -55 -22 -2 -25 -70 -14 -42 -3 -2
-11 -27 4 34 -1 -33 -19 -15 -11 -12 -57 -58
Net Cash Flow -0 -1 -0 -0 -0 0 2 -1 12 -4 -8 4

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 77 71 60 65 66 63 77 70 66 78 75 81
Inventory Days 363 389 393 300 234 249 245 240 295 228 268 260
Days Payable 90 74 75 50 90 66 56 85 75 54 60 58
Cash Conversion Cycle 350 386 378 316 210 246 265 226 286 252 283 283
Working Capital Days 27 61 65 108 58 93 126 109 141 131 155 151
ROCE % 10% 14% 14% 18% 15% 15% 21% 24% 15% 15% 28% 20%

Shareholding Pattern

Numbers in percentages

9 Recently
Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025
49.88% 49.88% 46.52% 45.92% 43.62% 43.50% 43.02% 42.95% 42.92% 43.08% 43.08% 43.08%
21.74% 21.86% 21.89% 22.27% 22.54% 23.01% 12.03% 12.63% 12.57% 11.90% 23.45% 25.41%
5.64% 5.73% 7.58% 6.49% 6.98% 7.56% 8.08% 8.02% 8.17% 8.19% 8.45% 6.41%
22.76% 22.54% 24.02% 25.34% 26.88% 25.95% 36.87% 36.40% 36.31% 36.82% 25.00% 25.09%
No. of Shareholders 81,18377,53775,05272,64273,03468,64065,22266,75867,35165,32267,58969,637

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls